Shares of Common Stock, $0.0001 par value SALES AGREEMENT September 28, 2010Sales Agreement • September 29th, 2010 • Cardium Therapeutics, Inc. • Biological products, (no disgnostic substances) • New York
THIS SALES AGREEMENT (the “Agreement”) dated as of September 28, 2010 is made and entered into by and between Brinson Patrick Securities Corporation, having its principal office at 1515 Broadway, 11th Floor, New York, New York 10036 (the “Sales Manager”) and Cardium Therapeutics, Inc., a corporation organized and existing under the laws of the State of Delaware (the “Company”).
